SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-002305
Filing Date
2022-01-26
Accepted
2022-01-26 17:02:12
Documents
14
Period of Report
2022-01-25
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46176
2 ex10-1.htm EX-10.1 17470
  Complete submission text file 0001493152-22-002305.txt   300872

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE foxwu-20220125.xsd EX-101.SCH 4150
4 XBRL DEFINITION FILE foxwu-20220125_def.xml EX-101.DEF 27960
5 XBRL LABEL FILE foxwu-20220125_lab.xml EX-101.LAB 38709
6 XBRL PRESENTATION FILE foxwu-20220125_pre.xml EX-101.PRE 26575
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7218
Mailing Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA SUITE 1039 NEW YORK NY 10020 917-284-8938
FoxWayne Enterprises Acquisition Corp. (Filer) CIK: 0001829999 (see all company filings)

IRS No.: 853093926 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39891 | Film No.: 22558715
SIC: 2834 Pharmaceutical Preparations